Effects of Cerebrospinal Fluids from Alzheimer and Non-Alzheimer Patients on Neurons-Astrocytes-Microglia Co-Culture.
Matilda IemmoloGiulia BivonaTommaso PiccoliAldo NicosiaGabriella SchieraCarlo Maria Di LiegroFabrizio Di PietraGiulio GhersiPublished in: International journal of molecular sciences (2024)
Alzheimer's disease (AD) is the most common form of dementia, characterized by the accumulation of β-amyloid plaques, tau tangles, neuroinflammation, and synaptic/neuronal loss, the latter being the strongest correlating factor with memory and cognitive impairment. Through an in vitro study on a neurons-astrocytes-microglia (NAM) co-culture system, we analyzed the effects of cerebrospinal fluid (CSF) samples from AD and non-AD patients (other neurodegenerative pathologies). Treatment with CSF from AD patients showed a loss of neurofilaments and spheroids, suggesting the presence of elements including CX3CL1 (soluble form), destabilizing the neurofilaments, cellular adhesion processes, and intercellular contacts. The NAM co-cultures were analyzed in immunofluorescence assays for several markers related to AD, such as through zymography, where the expression of proteolytic enzymes was quantified both in cell extracts and the co-cultures' conditioned medium (CM). Through qRT-PCR assays, several genes involved in the formation of β-amyloid plaque, in phosphorylation of tau, and in inflammation pathways and MMP expression were investigated.
Keyphrases
- end stage renal disease
- cognitive impairment
- ejection fraction
- cerebrospinal fluid
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- cognitive decline
- oxidative stress
- spinal cord
- inflammatory response
- traumatic brain injury
- stem cells
- high throughput
- mild cognitive impairment
- staphylococcus aureus
- bone marrow
- patient reported
- long non coding rna
- biofilm formation